MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma

65Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Objectives: MDM2 gene amplification is associated with well-differentiated (WDL) and dedifferentiated liposarcomas (DDL). Using fluorescent in situ hybridization (FISH), we sought to characterize various patterns of MDM2 amplification among the morphologic spectrum of liposarcoma. Methods: Forty-six cases of liposarcoma in various sites were examined and included 22 WDLs, 14 DLLs, and 10 negative control subjects. Results: The MDM2 amplification ratio (MDM2/CEP12) was lower in WDL (10.2) compared with ddl (18.3) cases (P = .0000002). An amplification ratio of 16 showed optimal sensitivity (0.86) and specificity (0.96) as a cutoff point for progression to DDL. Borderline areas, defined as tumors with increased cellularity and atypia but with preserved lipomatous differentiation, showed a significantly higher MDM2 ratio (17.5; P = .0007) compared with WDL. Central (retroperitoneal and intra-abdominal) tumors also showed a significantly higher MDM2 ratio than peripheral ones (P = .02). Conclusions: Differences in MDM2 amplification profiles among liposarcomas could help further define and predict progression to high-grade neoplasia.

Cite

CITATION STYLE

APA

Ware, P. L., Snow, A. N., Gvalani, M., Pettenati, M. J., & Qasem, S. A. (2014). MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma. American Journal of Clinical Pathology, 141(3), 334–341. https://doi.org/10.1309/AJCPLYU89XHSNHQO

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free